Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Melanoma of the Skin (All Stages^), 2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Utah7


Minnesota2


Vermont2


Iowa7


North Dakota2


Idaho7


Arizona2


South Dakota2


Nebraska2


Kentucky7


North Carolina2


Ohio2


Wisconsin2


West Virginia2


Maine2


New Hampshire2


Kansas2


Wyoming2


Florida2


Montana2


Washington4


Georgia7


Illinois7


Hawaii7


Maryland2


California7


Nevada2


South Carolina2


Alabama2


Colorado2


New Jersey7


Missouri2


Delaware2


Oklahoma2


Oregon2


Virginia2


Michigan2


Mississippi2


Tennessee2


Arkansas2


Louisiana7


Connecticut7


New York7


Pennsylvania2


New Mexico7


Alaska2


Rhode Island2


Texas7


Massachusetts7


District of Columbia2


Puerto Rico2


Indiana2

Notes:
Created by statecancerprofiles.cancer.gov on 07/05/2025 4:58 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.